GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eviana Health Corp (XCNQ:EHC) » Definitions » Return-on-Tangible-Equity

Eviana Health (XCNQ:EHC) Return-on-Tangible-Equity : -74.46% (As of Mar. 2019)


View and export this data going back to 2017. Start your Free Trial

What is Eviana Health Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Eviana Health's annualized net income for the quarter that ended in Mar. 2019 was C$-3.74 Mil. Eviana Health's average shareholder tangible equity for the quarter that ended in Mar. 2019 was C$5.02 Mil. Therefore, Eviana Health's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2019 was -74.46%.

The historical rank and industry rank for Eviana Health's Return-on-Tangible-Equity or its related term are showing as below:

XCNQ:EHC's Return-on-Tangible-Equity is not ranked *
in the Drug Manufacturers industry.
Industry Median: 6.47
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

Eviana Health Return-on-Tangible-Equity Historical Data

The historical data trend for Eviana Health's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eviana Health Return-on-Tangible-Equity Chart

Eviana Health Annual Data
Trend Jun15 Jun16 Jun17 Jun18
Return-on-Tangible-Equity
- - - -135.85

Eviana Health Quarterly Data
Jun15 Mar16 Jun16 Sep16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -106.15 -21.05 -7.90 -96.37 -74.46

Competitive Comparison of Eviana Health's Return-on-Tangible-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Eviana Health's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eviana Health's Return-on-Tangible-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eviana Health's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Eviana Health's Return-on-Tangible-Equity falls into.



Eviana Health Return-on-Tangible-Equity Calculation

Eviana Health's annualized Return-on-Tangible-Equity for the fiscal year that ended in Jun. 2018 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Jun. 2018 )  (A: Jun. 2017 )(A: Jun. 2018 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Jun. 2018 )  (A: Jun. 2017 )(A: Jun. 2018 )
=-4.485/( (-0.145+6.748 )/ 2 )
=-4.485/3.3015
=-135.85 %

Eviana Health's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2019 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2019 )  (Q: Dec. 2018 )(Q: Mar. 2019 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2019 )  (Q: Dec. 2018 )(Q: Mar. 2019 )
=-3.736/( (5.736+4.299)/ 2 )
=-3.736/5.0175
=-74.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2019) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Eviana Health  (XCNQ:EHC) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Eviana Health Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Eviana Health's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Eviana Health (XCNQ:EHC) Business Description

Traded in Other Exchanges
N/A
Address
5728 East Boulevard, Vancouver, BC, CAN, V6M 4M4
Eviana Health Corp produces and sells cannabinoid products from natural hemp strains of cannabis sativa for consumer health-care products, pharmaceuticals, nutraceuticals, and cosmeceuticals, as well as for topical creams and other health and wellness products.